Furthermore, pan-cancer analysis of S-phase enriched lncRNAs identified that SCAT1(CTD-2357A8.3) was differentially expressed in several cancers, SCAT1(CTD-2357A8.3) induced cell proliferation and correlated with poor prognosis in lung cancer (Ali et al., 2018), and these publications provided a novel biological function and mechanism of these lncRNAs in tumors. This evidence concerns the gene SCAT1 and cancer.